Incyte | Der Umsatz



Sales Veränderung Datum
Acadia Pharmaceuticals USD 244.32M 15.28M 2025-03
Agios Pharmaceuticals USD 8.7M 2.03M 2025-03
Alnylam Pharmaceuticals USD 594.19M 1.02M 2025-03
Amgen USD 8.15B 936M 2025-03
Biogen USD 2.43B 24.7M 2025-03
BioMarin Pharmaceutical USD 745M 2.31M 2025-03
Bristol-Myers Squibb USD 11.2B 1.14B 2025-03
Eli Lilly USD 12.73B 802.8M 2025-03
Exelixis USD 555.4M 11.35M 2025-03
Gilead Sciences USD 6.67B 899M 2025-03
Incyte USD 1.05B 128.7M 2025-03
Ionis Pharmaceuticals USD 132M 94.58M 2025-03
MacroGenics USD 19.35M 91.35M 2024-12
Merck USD 15.53B 94M 2025-03
Moderna USD 108M 858M 2025-03
Neurocrine Biosciences USD 572.6M 55.1M 2025-03
Novartis USD 13.15B 330M 2024-12
Novartis USD 13.56B 386M 2024-12
Pfizer USD 13.72B 4.04B 2025-03
PTC Therapeutics USD 190M 23.17M 2025-03
Regeneron Pharmaceuticals USD 3.03B 760M 2025-03
Sarepta Therapeutics USD 774.9M 116.49M 2025-03
Ultragenyx Pharmaceutical USD 139.29M 25.59M 2025-03
Vertex Pharmaceuticals USD 2.77B 142M 2025-03



Incyte Der Umsatz - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Jul 2025.